Pfizer Abandons Paxlovid for "Standard Risk Population"
16/06/2022
After the bad news about VRBPAC’s “expert” clown show approving “infant Covid Vaxx”, I was hoping that I could find
something good and exciting to write about, to cheer up my readers. I spent an
hour looking for good news with increasing desperation.
Fortunately, I found some great news. Pfizer is ending its
failed Paxlovid standard risk trial! We exposed Pfizer’s Paxlovid
medication as essentially snake oil that does not work, showed Pfizer’s corrupt motives, and made a lot of noise on substack and on Twitter. Brian Mowrey explained
that Paxlovid is a five-day PAUSE button,
not a STOP button. Hundreds of
people reported Paxlovid rebounds on Twitter and even corrupt “health experts”
could no longer deny that Paxlovid is a sham.
One such health expert describes his boosted wife (and himself)
rebounding from Paxlovid, and his boosted wife is sadly suffering from serious
long covid problems.
Our campaign thusly paid off, and embarrassed Pfizer is abandoning its attempts to trial its
non-working medication in
standard-risk patients.
Everyone is now aware that Paxlovid was never tested on the vaccinated. Everyone is also aware that it does not actually work in vaccinated
people.
The FDA, as always, tried to gaslight the unfortunate rebounders but failed to quell the wave of complaints.
This was a big victory. That said, will Pfizer relegate Paxlovid to the
few extremely high-risk unvaccinated patients? Of course not, what a stupid
question. This is Pfizer, after all.
Bourla: Half of All People Are High Risk
Instead, Pfizer CEO Bourla declared that 40-50% of people are “high
risk” and need to take Paxlovid anyway.
Try to think about this statement for a minute: most people, especially
by far the most people over 50, are vaccinated and boosted. Aren’t they
protected by safe and effective vaccines? Our health authorities said that
vaccines provide 98% protection against severe outcomes. Is Bourla saying that
half of the vaccinated people are high risk despite their multiple boosters? Is
Albert an antivaxxer?
Albert is not an antivaxxer, he is just a grifter. Since Paxlovid does
not work in standard risk people, he decided to label half of all people “high
risk”, in order to keep selling Paxlovid. Bourla again sidesteps the crucial
issue, that Paxlovid was never tested in the vaccinated and does not work in them. He wants everyone to forget this fact, and keep buying Paxlovid
despite it having never been trialed in the vaccinated.
Igor’s Newsletter
Israeli Data Explains Why
Pfizer Excluded Vaccinated People from Paxlovid Trials
14 days ago · 327 likes · 154
comments · Igor Chudov
Since suckers are born every minute, Pfizer will succeed and will keep
selling Paxlovid.
Unfortunately, suckers will also die every minute in
the coming years, which is very regrettable.
Paxlovid not Working in the Vaccinated is a Sign of
Immune Deficiency
Try to stop and think for a minute. Ask yourself a question: why,
exactly, is Paxlovid not working in the vaccinated?
The problem is not with Paxlovid, it is the same medication as given to
the unvaccinated. The problem is with the immune systems of the vaccinated. The
vaccinated cannot clear Covid, while replication is temporarily paused by
Paxlovid. The unvaccinated can. Why?
It is a question that I would like to explore, as it may be key to multiple
reinfections of the vaccinated, as well as to “less severe disease”
that the vaccinated are having, while simultaneously having higher viral loads.
Both phenomena are explained by lack of immune reaction to Sars-Cov-2
from deprogrammed immune systems that were unset and imprinted by several mRNA
spike protein transfections.
Part of “severe disease” comes from cytokine storms, caused by an
overreaction of immune systems. Well, if immune systems are
deprogrammed, they will not overreact — not even react properly — and will not
clear the virus either. They will not prevent reinfections, as well.
More on this later.
Source: https://igorchudov.substack.com/p/we-exposed-paxlovid-as-snake-oil?utm_source=email&s=r
